Chronic Myelogenous Leukemia Treatment–for health professionals (PDQ®)
SECTIONS
- General Information About Chronic Myelogenous Leukemia (CML)
- Stage Information for CML
- Treatment Option Overview for CML
- Chronic-Phase CML
- Accelerated-Phase CML
- Blastic-Phase CML
- Relapsing CML
- Key References for CML
- Changes to This Summary (01/22/2016)
- About This PDQ Summary
- View All Sections
Changes to This Summary (01/22/2016)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Updated statistics with estimated new cases and deaths for 2016 (cited American Cancer Society as reference 1).
Added this new section.
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
No hay comentarios:
Publicar un comentario